Advertisement
Advertisement
Trending on Urology Times
1
Retrospective study suggests differences in OAB therapy persistence among older adults
2
Behind the FDA approval of capivasertib for mHSPC, with Daniel J. George, MD
3
FDA gives nod to feasibility study of NanoKnife IRE for benign prostatic hyperplasia
4
Preserving Quality of Life in Metastatic Castration-Sensitive Prostate Cancer
5